Search for: "GlaxoSmithKline LLC" Results 61 - 80 of 179
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2021, 4:15 am by Gretchen Miller
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
11 Jun 2013, 10:50 am by John J. Sullivan
  The plaintiffs originally filed suit in the Philadelphia Court of Common Pleas, naming a number of defendants, including GlaxoSmithKline’s operating company, GlaxoSmithKline LLC (“GSK LLC”) and GSK LLC’s sole member, GlaxoSmithKline Holdings (“GSK Holdings”). [read post]
31 Oct 2007, 11:39 am
This morning, GlaxoSmithKline prevailed in the District Court for the Eastern District of Virginia and succeeded at enjoining the USPTO from making the Final Rules on claims and continuations effective. [read post]
10 Sep 2018, 8:19 am by Lebowitz & Mzhen
The Facts of the Case A doctor prescribed a patient Paxil, manufactured by GlaxoSmithKline (GSK) to treat the patient’s depression and anxiety. [read post]
16 Jul 2012, 8:22 am by Russell S. Whittle Esq. MSCC
GlaxoSmithKline, LLC, concluding that any private party may bring an action under §1395y(b)(3)(A), as it establishes a private cause of action for damages. [read post]
15 May 2023, 10:14 am by Courtenay C. Brinckerhoff
GlaxoSmithKline, LLC, which has come to be known as the “skinny label” case. [read post]
18 May 2020, 8:38 am by Lawrence B. Ebert
GlaxoSmithKline LLC, 713 F.3d 1090, 1096 (Fed.Cir. 2013) (“If an applicant chooses, she can challenge an examiner’s characterization in order to avoid any chancefor disclaimer, but the applicants in this case did not directly challenge the examiner’s characterization. [read post]
13 Oct 2014, 4:39 pm
The United States Court of Appeals for the Third Circuit has ordered that a drug defect lawsuit against GlaxoSmithKline LLC over its Paxil antidepressant medication be sent back to a state court. [read post]
21 Jul 2009, 6:56 am
The GlaxoSmithKline Poligrip Defendants (SmithKline Beecham Corp., GlaxoSmithKline Consumer Healthcare LLC, GlaxoSmithKline Consumer Healthcare, LP, and Block Drug Company, Inc.) supported the Plaintiffs' motion for consolidation, while the Proctor and Gamble Fixodent Defendants (The Procter & Gamble Manufacturing Co. and The Procter & Gamble Distributing LLC) opposed consolidation. [read post]
10 Jul 2010, 10:33 am by Williams Oinonen LLC
If you or a loved one suffered an injury or death due to Avandia, call Williams Oinonen LLC today to schedule a free appointment with our team of lawyers. [read post]
18 Dec 2023, 10:00 pm by Sherica Celine
Hear expert commentary from Tom Irving and Michelle O’Brien of the Marbury Law Group on the risk generic drug companies face when utilizing a skinny label in the aftermath of the Federal Circuit’s decision in Glaxosmithkline LLC v. [read post]
17 Jul 2022, 5:00 am by Dennis Crouch
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]